نتایج جستجو برای: hematopoietic stem cell transplantation

تعداد نتایج: 1898560  

Journal: :iranian journal of public health 0
ensieh nasli esfahani maryam ghodsi ali tootee camelia rambod bagher larijani akbar soltani

background: cell therapy has emerged as a promising curative intervention for several diseases including diabetes and wolfram syndrome (ws). the current study aimed to assess the effectiveness of clinical application of fetal-liver derived stem cells for treatment of patients with ws. methods: six patients with ws aged 23-34 (mean: 29.50, sd: 4.76) were recruited for the current phase 3 single-...

Journal: :Blood 2002
Perpétua Pinto do O Karin Richter Leif Carlsson

Hematopoietic stem cells (HSCs) are unique in their capacity to maintain blood formation following transplantation into immunocompromised hosts. Expansion of HSCs in vitro is therefore important for many clinical applications but has met with limited success because the mechanisms regulating the self-renewal process are poorly defined. We have previously shown that expression of the LIM-homeobo...

2010
ES Swenson ND Theise

Stem cell therapies may be valuable in treatment of inflammatory bowel disease (IBD). Here we focus on two very different types of stem cells - hematopoietic stem cells and mesenchymal stem cells. Myeloablation and hematopoietic stem cell transplantation alter host immune response by reconstituting the recipient's blood cell lines with donor cells. Autologous hematopoietic reconstitution may "r...

2014
Mingjuan Liu Caie Yang Lihui Liu Bing Shi Wenqing Hu Liping Ye Yongqing Zhang

BACKGROUND Currently, hematopoietic stem cell transplantation is still an essential treatment approach for leukemia. However, patients with leukemia often have weakened immune function, especially more seriously compromised cellular immune response, and appear to be at greater risk for tuberculosis infection during the transplantation process. We aimed to investigate the efficacy and safety of ...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran seyyedasadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hamdi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

post-remission treatment in patients with acute myeloid leukemia is still controversial. one potent choice for patients with no donor available is autologous stem cell transplantation. the median follow-up period was 18 months and the median age was 26 years old. in the review of 116 recently diagnosed aml patients (except aml- m3) who underwent autologous stem cell transplantation, 72.4% of pa...

Journal: :بینا 0
علیرضا برادران رفیعی ar baradaran-rafie ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم مهدی اصلانی m aslani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم حسین حسن پور h hasanpoor ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم مرجان زارع جوشقانی m zare joshaghani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم حسین جمالی h jamali دانشگاه علوم پزشکی شیراز محمد زارع جوشقانی m zare joshaghani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم بهرام عین الهی

purpose: to report the outcomes of conjunctival-limbal autograft (clau) in patients with unilateral total limbal stem cell deficiency (lscd) emphasizing surgical problems, complications, and their management. methods: in this prospective interventional case series, clau combined with amniotic membrane transplantation as a graft was performed on 26 patients with unilateral total lscd due to chem...

Journal: :iranian biomedical journal 0
مسعود سلیمانی masoud soleimani حسین مزدرانی hossein mozdarani علی اکبر پورفتح ا... aliakbar pourfathollah یوسف مرتضوی yousef mortazavi کامران علی مقدم kamran alimoghaddam مهین نیکوگفتار mahin nikogoftar زهرا زنوبی

many investigators have used xenogeneic, especially murine stromal cells and fetal calf serum to maintain and expand human stem cells. the proliferation and expansion of human hematopoietic stem cells in ex vivo culture were examined with the goal of generating a suitable protocol for expanding hematopoietic stem cells for patient transplantation. using primary fetal liver cells, we established...

Journal: :Haematologica 2014
Kazuyuki Murase Haesook T Kim O R Gregory Bascug Yutaka Kawano Jeremy Ryan Ken-ichi Matsuoka Matthew S Davids John Koreth Vincent T Ho Corey Cutler Philippe Armand Edwin P Alyea Bruce R Blazar Joseph H Antin Robert J Soiffer Anthony Letai Jerome Ritz

CD4 regulatory T cells play a critical role in establishment of immune tolerance and prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. The recovery and maintenance of regulatory T cells is dependent on homeostatic factors including the generation of naïve regulatory T cells from hematopoietic precursor cells, the proliferation and expansion of mat...

2014
Andrea I. Loewendorf Marie Csete Alan Flake

In utero hematopoietic stem cell transplantation (IUHCT) is an attractive approach and a potentially curative surgery for several congenital hematopoietic diseases. In practice, this application has succeeded only in the context of Severe Combined Immunodeficiency Disorders. Here, we review potential immunological hurdles for the long-term establishment of chimerism and discuss relevant models ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1998
J M Zijlmans J W Visser L Laterveer K Kleiverda D P Heemskerk P M Kluin R Willemze W E Fibbe

Blood cells transplantation is largely replacing bone marrow transplantation because engraftment is more rapid. This accelerated engraftment is thought to be mediated by relatively mature committed hematopoietic progenitor cells. Herein, we have used a modified rhodamine (Rho) staining procedure to identify and purify Rho+/++ (dull/bright) and Rho- (negative) subpopulations of hematopoietic pro...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید